Yingnian Lu

Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins

Aurelia A. Haller, Georg M. Lauer, Thomas H. King et al. · Vaccine · 2006 · 105 citations

Life Sciences, Immunology, Infectious Diseases +14

Mutation-Selective Tumor Remission with Ras-Targeted, Whole Yeast-Based Immunotherapy

Yingnian Lu, Donald Bellgrau, Lori D. Dwyer‐Nield et al. · Cancer Research · 2004 · 73 citations

Medicine, Immunology, Oncology +10

α-Fe2O3 based nanotherapeutics for near-infrared/dihydroartemisinin dual-augmented chemodynamic antibacterial therapy

Yueying Xu, Le Xiao, Jia Chen et al. · Acta Biomaterialia · 2022 · 72 citations

Natural Sciences, Materials Science, Medicinal Chemistry +12

A Whole Recombinant Yeast-Based Therapeutic Vaccine Elicits HBV X, S and Core Specific T Cells in Mice and Activates Human T Cells Recognizing Epitopes Linked to Viral Clearance

Thomas H. King, Charles B. Kemmler, Zhimin Guo et al. · PLoS ONE · 2014 · 70 citations · Full text

Pharmacy, Immunology, Infectious Diseases +17

Epidermal Growth Factor Receptor Mediates Silibinin-Induced Cytotoxicity in a Rat Glioma Cell Line

Lin Qi, Rana P. Singh, Yingnian Lu et al. · Cancer Biology & Therapy · 2003 · 32 citations · Full text

Medicine, Oncology, Pharmacology +16